Buy 4-FMA Pellets 150mg

Product Overview

4-FMA Pellets 150mg (CAS 351-03-1) represent a premium, synthetic phenethylamine reference standard formulated as precise, pre-weighed tablets for advanced analytical chemistry, forensic toxicology, and chromatographic method development. This brandless, generic compound achieves exceptional ≥98% purity through controlled synthesis processes, ensuring batch-to-batch consistency that researchers demand for reproducible experimental outcomes. Supplied exclusively for non-clinical laboratory environments, these pellets facilitate streamlined workflows in professional research facilities worldwide, from academic institutions to industrial R&D laboratories. The tablet format eliminates weighing variability, supporting high-throughput screening and quantitative analysis protocols. Available through compliant eCommerce platforms optimized for WooCommerce, this product meets international regulatory standards for research chemical distribution. Researchers appreciate the convenience of ready-to-use dosing in controlled settings, where precision directly impacts data integrity. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

The compound 4-FMA, systematically named 4-Fluoromethamphetamine, is uniquely identified by CAS Registry Number 351-03-1, with the molecular formula C₁₀H₁₄FN and a molecular weight of 167.23 g/mol for the free base form (hydrochloride salt at 203.7 g/mol). Common laboratory synonyms include 1-(4-Fluorophenyl)-N-methylpropan-2-amine, 4-FMP, and para-fluoro-N-methylamphetamine, aiding in precise cataloging across global chemical databases. Structurally classified as a substituted amphetamine derivative within the phenethylamine family, specifically a fluoroamphetamine analog, it serves as a critical reference material in analytical protocols. This classification positions it alongside other halogenated amphetamines used in spectroscopy, mass spectrometry, and separation science. The defined chemical identity enables seamless integration into laboratory information management systems (LIMS), ensuring accurate tracking from procurement through experimental execution. Researchers rely on these standardized identifiers to validate method specificity and sensitivity in complex matrices.

Chemical & Physical Characteristics

4-FMA Pellets 150mg manifest as uniform, white to off-white compressed tablets, with the active crystalline powder exhibiting a characteristic fine texture prior to pressing. The free base form displays a melting point range of approximately 150-152°C under inert conditions, while solubility profiles include high compatibility with polar aprotic solvents such as dimethylformamide (DMF) at >30 mg/mL, dimethyl sulfoxide (DMSO) at similar levels, and ethanol at 30 mg/mL. Moderate aqueous solubility occurs in phosphate-buffered saline (PBS, pH 7.2) around 10 mg/mL, supporting dissolution studies in simulated lab environments. The pressed matrix incorporates inert excipients to enhance mechanical stability, preventing friability during transport and handling. Under desiccated, ambient conditions, the compound maintains physical integrity, with no significant degradation observed over extended periods. These measurable attributes—appearance, form, solubility, and thermal behavior—provide researchers with predictable parameters for experimental design, from HPLC mobile phase preparation to NMR sample solubilization. The pellet’s uniformity ensures consistent surface area exposure in dissolution kinetics evaluations.

Purity & Analytical Verification

Every production batch of 4-FMA Pellets 150mg is certified to meet or exceed ≥98% purity, with comprehensive verification employing orthogonal analytical methodologies including reversed-phase High-Performance Liquid Chromatography (HPLC) at 254 nm, Gas Chromatography with Flame Ionization Detection (GC-FID), proton and carbon-13 Nuclear Magnetic Resonance (NMR) spectroscopy, and high-resolution Liquid Chromatography-Mass Spectrometry (LC-MS). These techniques quantify not only the primary analyte but also detect and speciate impurities such as unreacted precursors, fluorinated byproducts, and residual solvents to parts-per-million levels. Certificates of Analysis (COAs) accompany each lot, presenting tabular data on assay results (>98.0% w/w), enantiomeric excess (where applicable), heavy metals (<10 ppm), and water content (<0.5%). COAs remain accessible via secure digital portals post-purchase, with hard copies available upon request. This multi-faceted verification aligns with United States Pharmacopeia (USP) and European Pharmacopoeia guidelines for reference standards, empowering laboratories to demonstrate chain-of-custody compliance in audited environments.

Quality Control & Batch Integrity

Batch-controlled manufacturing underpins the integrity of 4-FMA Pellets 150mg, with full lot traceability implemented from incoming raw material inspection through final release. Each production run undergoes in-process controls for reaction completion, intermediate purification yields, and excipient blending homogeneity, followed by rigorous final testing for weight variation (≤5% RSD), content uniformity (≤2% RSD), and friability (<1% loss). Retained reference samples from every batch enable retrospective analysis for up to seven years. Comprehensive documentation packages—including batch manufacturing records, raw material COAs, environmental monitoring logs, and stability data—are maintained in immutable digital formats. Internal quality assurance mirrors ISO 17025 accreditation standards, with optional third-party audits available for institutional buyers. This systematic approach minimizes risks of cross-contamination or variability, delivering confidence to principal investigators managing grant-funded projects or regulatory submissions.

Safety, Handling & Laboratory Precautions

Laboratory handling of 4-FMA Pellets 150mg requires strict adherence to institutional chemical hygiene plans within certified Class II biosafety cabinets or fume hoods achieving >100 linear feet per minute airflow. Essential personal protective equipment (PPE) includes chemical-resistant nitrile gloves (8-mil thickness), ANSI Z87.1-compliant safety goggles, flame-retardant lab coats, and closed-toe footwear. Trained personnel must employ secondary containment for transfers, avoiding direct skin or inhalation exposure. Incompatibilities with strong oxidizing agents (e.g., permanganates), mineral acids, and alkaline hydrolyzing agents necessitate dedicated storage cabinets. Spill response protocols involve non-reactive absorbents, HEPA vacuuming, and decontamination with 70% isopropanol. The provided Safety Data Sheet (SDS) details GHS classifications, exposure limits (if established), and emergency procedures, ensuring alignment with OSHA Laboratory Standard 29 CFR 1910.1450. These precautions establish baseline laboratory safety without extending to physiological considerations.

Packaging, Labeling & Storage

Professional research-grade packaging for 4-FMA Pellets 150mg features amber glass or high-density polyethylene (HDPE) containers with induction-sealed, tamper-evident closures and integrated desiccants to mitigate hydrolytic degradation. Units are further protected in child-resistant, nitrogen-flushed pouches for transit stability. Globally Harmonized System (GHS)-compliant labels prominently display CAS 351-03-1, ≥98% purity, hazard pictograms (exclamation mark), signal word “Warning,” research-only designation, and lot-specific QR codes linking to digital COAs. Recommended storage at controlled room temperature (15-25°C), away from direct light and humidity sources, preserves chemical stability for a minimum of five years; sub-zero refrigeration (-20°C) extends this further. Post-access resealing with parafilm tape prevents moisture ingress, safeguarding multi-year research timelines.

Intended Research Use & Market Positioning

4-FMA Pellets 150mg find primary application in analytical chemistry for HPLC/GC method validation, forensic impurity profiling, and mass spectral library expansion within toxicology laboratories. Additional utility spans pharmaceutical R&D for analog synthesis studies, environmental monitoring of designer compounds, and educational demonstrations in organic chemistry curricula. The precise 150mg dosing supports quantitative recovery experiments, calibration curve generation, and limit-of-detection determinations. Marketed as a versatile, brandless alternative to proprietary standards, it appeals to contract research organizations (CROs), university core facilities, and industrial QA/QC departments seeking cost-effective, compliant reagents. Bulk configurations enhance scalability for high-volume screening initiatives.

Ordering, Availability & Fulfillment

4-FMA Pellets 150mg maintain consistent stock levels for immediate order processing via secure WooCommerce interfaces compatible with major credit cards, wire transfers, and cryptocurrency gateways. Orders received before 2 PM EST dispatch within 24 hours, utilizing tracked carriers like DHL Express or FedEx International Priority for 3-7 day global delivery. Discreet, neutral outer packaging conceals contents while inner labels ensure customs compliance. Dedicated account managers provide real-time inventory checks, expedited COA delivery, and volume discount quotations. Responsive 24/7 support resolves shipping queries, facilitating uninterrupted research momentum.

Legal & Regulatory Disclaimer

4-FMA Pellets 150mg (CAS 351-03-1) distributed strictly for laboratory research purposes only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Purchasers assume complete responsibility for ascertaining and adhering to all pertinent local, national, and international laws, regulations, and import/export restrictions. Seller disclaims liability for unauthorized applications; all sales subject to end-user verification. Consult legal counsel and jurisdictional authorities prior to acquisition.